1 / 35

Biochemie IV – Struktur und Dynamik von Biomolekülen II. (Mittwochs 8-10 h, INF 230, klHS)

Biochemie IV – Struktur und Dynamik von Biomolekülen II. (Mittwochs 8-10 h, INF 230, klHS) 30.4. Jeremy Smith: Intro to Molecular Dynamics Simulation. 7.5. Stefan Fischer: Molecular Modelling and Force Fields. 14.5. Matthias Ullmann: Current Themes in Biomolecular Simulation.

dustin
Download Presentation

Biochemie IV – Struktur und Dynamik von Biomolekülen II. (Mittwochs 8-10 h, INF 230, klHS)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Biochemie IV – Struktur und Dynamik von Biomolekülen II. (Mittwochs 8-10 h, INF 230, klHS) 30.4. Jeremy Smith: Intro to Molecular Dynamics Simulation. 7.5. Stefan Fischer: Molecular Modelling and Force Fields. 14.5. Matthias Ullmann: Current Themes in Biomolecular Simulation. 21.5. Ilme Schlichting: X-Ray Crystallography-recent advances (I). 28.5. Klaus Scheffzek: X-Ray Crystallography-recent advances (II). 4.6. Irmi Sinning: Case Study in Protein Structure. 11.6. Michael Sattler: NMR Applications in Structural Biology. 18.6. Jörg Langowski: Brownian motion basics. 25.6. Jörg Langowski: Single Molecule Spectroscopy. 2.7. Karsten Rippe: Scanning Force Microscopy. 9.7.Jörg Langowski: Single Molecule Mechanics. 16.7. Rasmus Schröder: Electron Microscopy. 23.7. Jeremy Smith: Biophysics, the Future, and a Party.

  2. Peptide:Membrane Interactions

  3. GRAMICIDIN S - cyclo(Leu-DPhe-Pro-Val-Orn)2 - Powerful but nonspecific antimicrobial agent. - Principal target : bacterial or erythrocyte membranes.

  4. Structure- Antimicrobial Activity Relationships: Two basic residues (e.g. Orn) on same face - required. Hydrophobic residues in Leu/Val positions - required.  sheet and  turns - required. : Sidedness Hypothesis (Schwyzer, 1958, Kato & Izumiya, 1977)

  5. Molecular Dynamics of Gramicidin S in DMSO Backbone: Stays in one conformation Average deviation from NMR: 18o NMR: Xu et al 1995.

  6. Order parameters of the sn-2 chains of DMPC. Hydrated DMPC -Douliez et al 1975 Bound Lipids - Disordered Free lipids - more ordered

  7. Scattering Experiments

  8. Lysozyme in explicit water

  9. STÉPHANIE HÉRY DANIEL GENEST Scattering of X-Rays by Protein Crystals Real Crystal Ideal Crystal + Perturbations =

  10. Molecular Dynamics of Lysozyme Unit Cell Full Trajectory Experimental Rigid-Body Decomposition Rigid-Body Fit (R-factor re: Full Trajectory = 5.3%)

  11. FRANCI MERZEL Protein Hydration. Svergun et al PNAS 1998: First 3Å hydration layer around lysozyme ~10% denser than bulk water

  12. Geometric Rg from MD simulation = 14.10.1Å

  13. (d) (d) Bulk Water d Bulk Water Average Density Present Even if Water UNPERTURBED from Bulk o(d) Bulk Water Radial Water Density Profiles Water Protein o(d)  10% increase o(d)- (d) = Perturbation from Bulk  5% increase

  14. What determines water density variations at a protein surface?

  15. Simple View of Protein Surface (1) Topography h=Surface Topographical Perturbation Protuberance L=3 surface Depression L=17 surface + (2) Electric Field qi qj qk

  16. Surface Topography, Electric Field and Density Variations Low  High  O High  H H High 

  17. Conclusions (1) Simulation and Experimental I(q) in Good Agreement (2) First Hydration Layer (0-3Å) ~15% Density Increase of which: - ~10% Unperturbed - ~5% Perturbed Fewer Disorienting Bulk Water Dipoles Water Dipoles Align with Protein E Field Water Density Variations Correlated with Surface Topography and Local E Field from Protein

  18. Macromolecular Complexes

  19. More Proteins Protein 1 Protein 2 Complex Formation Conformational Change Function

  20. Structures of Macromolecular Complexes • Very few experimentally determined • e.g. antibodies:antigens • ~1000 antibody sequences known • ~100 antibody structures known • ~10 antibody:antigen complex structures known • Can we use calculation?

  21. Homology Modelling Can derive structures for sequences with >20-30% sequence identity when aligned with sequence of known structure.

  22. Structures of Isolated Components? • - crystallography • - NMR • - Homology Modelling • Structure of Complex? • Rigid-Body Shape Complementarity • (based on hydrophobic effect and van der Waals packing) • Conformational Change on Complexation? • Electrostatic Complementarity? • Solvation Effects? • Experiment?

  23. Functional Binding Site on Toxin  Red: Affinity Lowered >100-fold Yellow: Affinity Lowered 10-100 fold

  24. Modelling of Isolated Antibody Homology Model of Framework Residues. Complementarity Determining Region Loops (CDRs): (i) Uniform Conformational Searching (ii) Canonical Loop Modelling (iii) Data-Base Searching of Loop Conformations (iv) Molecular Dynamics in vacuo and with solvated CDRs. > 90 models. Clustering and Screening for Consistency with Experimental Antibody Structures. 4 Dynamically Interconvertible Models.

  25. Modelling of Ab:Ag Complex Initial Generation Low -Resolution Shape Complementarity. > 41,585 models Clustering and Screening for: (i) Buried Surface Area. (ii) Electrostatic Complementarity. (iii) Consistency with existing Ab:Ag complex structures. > 18 models. Refinement of Atomic-Detail Models with Molecular Dynamics in Explicit Solvent. 6 Models.

  26. Toxin  and M 23 Functional Binding Sites Red - >100 fold affinity loss on mutation Yellow - 10-100 fold affinity loss on mutation

  27. Three Models of Calculated M23 Paratope Red: Residues contacting antigen energy core Yellow: Residues contacting functional epitope

  28. Orientation of toxin  on M23 combining site in the two remaining models.

  29. Annexin V - Pathway for Conformational Transition

  30. Charge Transfer in Biological Systems • Ions, Electrons...

  31. NICOLETA BONDAR MARCUS ELSTNER STEFAN FISCHER SANDOR SUHAI Proton Transfer Step #1 in Bacteriorhodopsin

More Related